MediPharm Labs Corp. (TSE:LABS – Get Free Report) rose 7.7% during trading on Wednesday . The company traded as high as C$0.07 and last traded at C$0.07. Approximately 187,500 shares changed hands during trading, a decline of 13% from the average daily volume of 214,411 shares. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The firm has a market capitalization of C$28.77 million, a P/E ratio of -1.75 and a beta of 0.88. The stock has a 50-day moving average of C$0.07 and a 200 day moving average of C$0.07. The company has a debt-to-equity ratio of 5.90, a quick ratio of 3.10 and a current ratio of 3.11.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
See Also
- Five stocks we like better than MediPharm Labs
- Short Selling: How to Short a Stock
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- About the Markup Calculator
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Calculate Stock Profit
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
